Content about Salix Pharmaceuticals

September 5, 2012

The Food and Drug Administration will not decide whether to approve a drug for diarrhea in HIV patients as it continues to review the regulatory approval application for it, the drug's manufacturer said.

November 9, 2011

Salix to acquire Oceana Therapeutics

Salix Pharmaceuticals has entered a definitive agreement to acquire all outstanding stock of a provider of gastroenterology and urology therapeutics.

August 30, 2011

FDA accepts application for opioid-induced constipation drug

The Food and Drug Administration has accepted a regulatory approval application from Progenics Pharmaceuticals and Salix Pharmaceuticals seeking an additional approval for a pain drug.

May 9, 2011

Napo sues Salix over breach of collaboration agreement commitments

Napo Pharmaceuticals has filed a lawsuit against Salix Pharmaceuticals, alleging that the latter breached commitments under an agreement to develop and commercialize a proprietary gastrointestinal compound.

April 20, 2011

Salix granted three patents for Xifaxan

The U.S. Patent and Trademark Office has awarded Salix Pharmaceuticals three patents related to a drug used for travelers’ diarrhea.

April 6, 2011

Salix, Lupin ink technology deal for Xifaxan

Indian drug maker Lupin and U.S. drug maker Salix Pharmaceuticals announced Wednesday a licensing deal for technology related to a drug for traveler’s diarrhea.

March 8, 2011

Salix issued CRL for Xifaxan

The Food and Drug Administration declined to approve a drug made by Salix Pharmaceuticals for irritable bowel syndrome, Salix said Tuesday.

February 7, 2011

Salix, Progenics ink licensing deal for Relistor

Salix Pharmaceuticals and Progenics Pharmaceuticals have entered a licensing agreement for a drug used to treat side effects of opioid use.

May 19, 2010

Salix receives patent for IBS treatment

The U.S. Patent and Trademark Office has issued a patent to Salix Pharmaceuticals for a...